Cart summary

You have no items in your shopping cart.

Rasagiline Mesylate

SKU: orb1226048

Description

Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.(In Vitro):Rasagiline (0.25 nM; 96 hours) significantly increases the proliferation rates of SH-SY5Y and 1242-MG upon Dexamethasone (10 μM) treatment.(In Vivo):Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Motor behavioural tests show improvements in motor deficits associated with 2.5 mg/kg Rasagiline therapy.

Images & Validation

Key Properties

CAS Number161735-79-1
MW267.34
Purity>98% (HPLC)
FormulaC13H17NO3S
SMILESCS(=O)(=O)O.C#CCN[C@@H]1CCC2=CC=CC=C12
TargetMAO
SolubilitySoluble in water

Bioactivity

In Vivo
Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Motor behavioural tests show improvements in motor deficits associated with 2.5 mg/kg Rasagiline therapy. Animal model: (PLP)-α-synuclein transgenic mice over 6 months of age. Dosage: Low-(0.8 mg/kg b. w.) and high dose (2.5 mg/kg b. w.). Administration: Administered subcutaneously every 24 h for a total period of 4 weeks (from day 1 till day 28 of the experiment). Result: Low dose treatment did not show protective efficacy in striatum with number of neurons similar to placebo treated MSA mice. High dose was associated with about 15% rescue of DARPP-32 immunoreactive striatal neurons. Low dose treatment had no effect on nigral neuronal loss, but high dose completely protected nigral neurons with numbers comparable to healthy controls.
In Vitro
Rasagiline (0.25 nM; 96 hours) significantly increases the proliferation rates of SH-SY5Y and 1242-MG upon Dexamethasone (10 μM) treatment. Cell Viability Assay Cell line: Neuroblastoma SH-SY5Y, and glioblastoma 1242-MG. Concentration: 0.25 nM Incubation time: 96 hours. Result: Caused ~60% increase in the cell proliferation rate for SH-SY5Y cells treated with Dexamethasone. Caused ~35% increase in cell proliferation rate for 1242-MG cells treated with Dexamethasone.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Rasagiline Mesylate [orb1300309]

    99.33%

    161735-79-1

    267.34

    C13H17NO3S

    25 mg, 50 mg, 100 mg, 200 mg
  • Rasagiline-13C3 (mesylate) [orb1693343]

    1391052-18-8

    270.32

    C13H17NO3S

    1 mg
  • (S)-Rasagiline mesylate [orb1708289]

    202464-88-8

    267.34

    C13H17NO3S

    50 mg, 100 mg, 25 mg
  • Rasagiline 13C3 mesylate racemic [orb1990411]

    1216757-55-9

    270.32

    C13H17NO3S

    100 mg, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Rasagiline Mesylate (orb1226048)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
25 mg
$ 80.00
50 mg
$ 90.00
100 mg
$ 130.00
200 mg
$ 160.00